AVTX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Avalo Therapeutics Inc (AVTX).


$77.23M Market Cap.

As of 03/20/2025 5:00 PM ET (MRY) • Disclaimer

AVTX Market Cap. (MRY)


AVTX Shares Outstanding (MRY)


AVTX Assets (MRY)


Total Assets

$150.73M

Total Liabilities

$17.70M

Total Investments

$131.00K

AVTX Income (MRY)


Revenue

$441.00K

Net Income

-$35.13M

Operating Expense

$69.32M

AVTX Cash Flow (MRY)


CF Operations

-$49.06M

CF Investing

$356.00K

CF Financing

$175.85M

AVTX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

AVTX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$150,732,000 (618.01%)

$20,993,000 (-37.08%)

$33,367,000 (-58.40%)

$80,214,000 (83.33%)

Assets Current

$138,890,000 (1554.44%)

$8,395,000 (-48.86%)

$16,416,000 (-73.46%)

$61,845,000 (137.82%)

Assets Non-Current

$11,842,000 (-6.00%)

$12,598,000 (-25.68%)

$16,951,000 (-7.72%)

$18,369,000 (3.49%)

Goodwill & Intangible Assets

$10,502,000 (0.00%)

$10,502,000 (-27.11%)

$14,409,000 (-0.26%)

$14,447,000 (-9.67%)

Shareholders Equity

$133,032,000 (1721.36%)

$7,304,000 (166.92%)

-$10,915,000 (-147.29%)

$23,082,000 (-6.03%)

Property Plant & Equipment Net

$1,209,000 (-38.47%)

$1,965,000 (-18.50%)

$2,411,000 (-10.54%)

$2,695,000 (67.70%)

Cash & Equivalents

$134,565,000 (1714.52%)

$7,416,000 (-43.76%)

$13,187,000 (-75.86%)

$54,636,000 (188.21%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$88,000 (0%)

$0 (0%)

Total Investments

$131,000 (0.00%)

$131,000 (0.00%)

$131,000 (-42.29%)

$227,000 (52.35%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$131,000 (0.00%)

$131,000 (0.00%)

$131,000 (-42.29%)

$227,000 (52.35%)

Inventory

$0 (0%)

$0 (0%)

$20,000 (-47.37%)

$38,000 (1166.67%)

Trade & Non-Trade Receivables

$611,000 (349.26%)

$136,000 (-92.91%)

$1,919,000 (-60.01%)

$4,799,000 (9.44%)

Trade & Non-Trade Payables

$283,000 (-36.55%)

$446,000 (-84.52%)

$2,882,000 (-14.46%)

$3,369,000 (30.89%)

Accumulated Retained Earnings (Deficit)

-$370,263,000 (-10.48%)

-$335,134,000 (-10.31%)

-$303,824,000 (-15.89%)

-$262,166,000 (-47.46%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$270,000 (74.19%)

$155,000 (9.93%)

$141,000 (24.78%)

$113,000 (25.56%)

Total Debt

$0 (0%)

$0 (0%)

$19,416,000 (-40.86%)

$32,833,000 (0%)

Debt Current

$0 (0%)

$0 (0%)

$5,930,000 (0%)

$0 (0%)

Debt Non-Current

$0 (0%)

$0 (0%)

$13,486,000 (-58.93%)

$32,833,000 (0%)

Total Liabilities

$17,700,000 (29.30%)

$13,689,000 (-69.09%)

$44,282,000 (-22.49%)

$57,132,000 (197.67%)

Liabilities Current

$6,960,000 (50.71%)

$4,618,000 (-79.12%)

$22,114,000 (11.19%)

$19,888,000 (30.63%)

Liabilities Non-Current

$10,740,000 (18.40%)

$9,071,000 (-59.08%)

$22,168,000 (-40.48%)

$37,244,000 (838.61%)

AVTX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$441,000 (-77.08%)

$1,924,000 (-89.34%)

$18,051,000 (234.40%)

$5,398,000 (-19.42%)

Cost of Revenue

-$366,000 (-128.50%)

$1,284,000 (-62.61%)

$3,434,000 (130.32%)

$1,491,000 (397.00%)

Selling General & Administrative Expense

$17,241,000 (67.39%)

$10,300,000 (-50.27%)

$20,711,000 (-16.01%)

$24,658,000 (24.79%)

Research & Development Expense

$24,437,000 (77.29%)

$13,784,000 (-55.97%)

$31,308,000 (-47.68%)

$59,835,000 (85.86%)

Operating Expenses

$69,319,000 (147.65%)

$27,991,000 (-46.23%)

$52,057,000 (-39.50%)

$86,041,000 (8.58%)

Interest Expense

-$3,317,000 (-197.07%)

$3,417,000 (-18.06%)

$4,170,000 (74.40%)

$2,391,000 (4979.59%)

Income Tax Expense

$114,000 (714.29%)

$14,000 (-50.00%)

$28,000 (114.29%)

-$196,000 (92.98%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$27,000 (103.05%)

Consolidated Income

-$35,129,000 (-11.37%)

-$31,544,000 (24.28%)

-$41,658,000 (50.63%)

-$84,376,000 (-32.88%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$35,129,000 (-11.37%)

-$31,544,000 (24.28%)

-$41,658,000 (50.63%)

-$84,376,000 (-32.88%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$35,129,000 (-11.37%)

-$31,544,000 (24.28%)

-$41,658,000 (50.63%)

-$84,376,000 (-32.88%)

Weighted Average Shares

$10,393,954 (1196.66%)

$801,593 (-91.49%)

$9,414,104 (0.58%)

$9,359,782 (49.94%)

Weighted Average Shares Diluted

-

-

-

-

Earning Before Interest & Taxes (EBIT)

-$38,332,000 (-36.35%)

-$28,113,000 (24.95%)

-$37,460,000 (54.42%)

-$82,181,000 (-23.87%)

Gross Profit

$807,000 (26.09%)

$640,000 (-95.62%)

$14,617,000 (274.12%)

$3,907,000 (-38.94%)

Operating Income

-$68,512,000 (-150.49%)

-$27,351,000 (26.95%)

-$37,440,000 (54.42%)

-$82,134,000 (-12.75%)

AVTX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$356,000 (367.67%)

-$133,000 (-40.00%)

-$95,000 (15.93%)

-$113,000 (-101.02%)

Net Cash Flow from Financing

$175,849,000 (602.22%)

$25,042,000 (270.37%)

-$14,699,000 (-113.77%)

$106,762,000 (138.39%)

Net Cash Flow from Operations

-$49,056,000 (-59.90%)

-$30,680,000 (-14.69%)

-$26,751,000 (62.27%)

-$70,892,000 (-74.87%)

Net Cash Flow / Change in Cash & Cash Equivalents

$127,149,000 (2303.24%)

-$5,771,000 (86.11%)

-$41,545,000 (-216.19%)

$35,757,000 (132.54%)

Net Cash Flow - Business Acquisitions and Disposals

$356,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

-$133,000 (-40.00%)

-$95,000 (15.93%)

-$113,000 (-79.37%)

Issuance (Repayment) of Debt Securities

$0 (0%)

-$21,244,000 (-43.48%)

-$14,806,000 (-145.00%)

$32,900,000 (0%)

Issuance (Purchase) of Equity Shares

$185,068,000 (299.84%)

$46,286,000 (43157.94%)

$107,000 (-99.86%)

$73,862,000 (64.58%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$5,852,000 (68.31%)

$3,477,000 (-53.97%)

$7,554,000 (-7.56%)

$8,172,000 (20.42%)

Depreciation Amortization & Accretion

$169,000 (6.96%)

$158,000 (-4.82%)

$166,000 (-89.98%)

$1,657,000 (-10.09%)

AVTX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

183.00% (449.55%)

33.30% (-58.89%)

81.00% (11.88%)

72.40% (-24.19%)

Profit Margin

-7965.80% (-385.87%)

-1639.50% (-610.36%)

-230.80% (85.23%)

-1563.10% (-64.90%)

EBITDA Margin

-8653.70% (-495.57%)

-1453.00% (-603.29%)

-206.60% (86.15%)

-1491.70% (-54.93%)

Return on Average Equity (ROAE)

-502.60% (65.09%)

-1439.90% (-208.46%)

1327.60% (564.68%)

-285.70% (-56.72%)

Return on Average Assets (ROAA)

-29.20% (74.36%)

-113.90% (-12.11%)

-101.60% (8.80%)

-111.40% (5.11%)

Return on Sales (ROS)

-8692.10% (-494.86%)

-1461.20% (-604.19%)

-207.50% (86.37%)

-1522.40% (-53.73%)

Return on Invested Capital (ROIC)

42.50% (-97.69%)

1841.70% (631.21%)

-346.70% (64.77%)

-984.20% (-156.30%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.94 (-1070.00%)

-0.08 (92.97%)

-1.14 (44.49%)

-2.05 (33.22%)

Price to Sales Ratio (P/S)

175.12 (4519.31%)

3.79 (44.20%)

2.63 (-92.57%)

35.37 (19.82%)

Price to Book Ratio (P/B)

0.58 (-41.84%)

1 (122.98%)

-4.35 (-152.55%)

8.27 (2.73%)

Debt to Equity Ratio (D/E)

0.13 (-92.90%)

1.87 (146.19%)

-4.06 (-263.92%)

2.48 (216.90%)

Earnings Per Share (EPS)

-7.94 (93.04%)

-114 (-2473.36%)

-4.43 (55.48%)

-9.95 (3.59%)

Sales Per Share (SPS)

0.04 (-98.25%)

2.4 (25.20%)

1.92 (232.24%)

0.58 (-46.23%)

Free Cash Flow Per Share (FCFPS)

-4.72 (87.72%)

-38.44 (-1247.83%)

-2.85 (62.40%)

-7.59 (-16.64%)

Book Value Per Share (BVPS)

12.8 (40.46%)

9.11 (886.19%)

-1.16 (-147.00%)

2.47 (-37.33%)

Tangible Assets Book Value Per Share (TABVPS)

13.49 (3.08%)

13.09 (549.85%)

2.01 (-71.34%)

7.03 (58.02%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

-1 (50.00%)

-2 (0.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

0.12 (18.45%)

0.1 (107.76%)

-1.33 (29.55%)

-1.89 (25.96%)

Asset Turnover

0 (-94.29%)

0.07 (-84.09%)

0.44 (519.72%)

0.07 (-42.74%)

Current Ratio

19.95 (997.63%)

1.82 (145.01%)

0.74 (-76.14%)

3.11 (82.08%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$49,056,000 (-59.21%)

-$30,813,000 (-14.78%)

-$26,846,000 (62.19%)

-$71,005,000 (-74.88%)

Enterprise Value (EV)

-$4,671,922 (-61.85%)

-$2,886,500 (-105.83%)

$49,518,026 (-67.37%)

$151,753,309 (-7.60%)

Earnings Before Tax (EBT)

-$35,015,000 (-11.05%)

-$31,530,000 (24.26%)

-$41,630,000 (50.78%)

-$84,572,000 (-27.57%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$38,163,000 (-36.52%)

-$27,955,000 (25.04%)

-$37,294,000 (53.69%)

-$80,524,000 (-24.85%)

Invested Capital

-$1,295,000 (16.07%)

-$1,543,000 (-150.21%)

$3,073,000 (-87.24%)

$24,076,000 (474.96%)

Working Capital

$131,930,000 (3392.98%)

$3,777,000 (166.29%)

-$5,698,000 (-113.58%)

$41,957,000 (289.21%)

Tangible Asset Value

$140,230,000 (1236.67%)

$10,491,000 (-44.66%)

$18,958,000 (-71.17%)

$65,767,000 (136.90%)

Market Capitalization

$77,227,078 (958.70%)

$7,294,500 (-84.63%)

$47,448,026 (-75.15%)

$190,940,309 (-3.45%)

Average Equity

$6,989,500 (219.05%)

$2,190,750 (169.82%)

-$3,137,750 (-110.62%)

$29,533,500 (-15.19%)

Average Assets

$120,305,500 (334.58%)

$27,683,250 (-32.50%)

$41,009,250 (-45.86%)

$75,750,000 (40.10%)

Invested Capital Average

-$90,147,000 (-5805.47%)

-$1,526,500 (-114.13%)

$10,803,250 (29.38%)

$8,350,250 (320.02%)

Shares

10,393,954 (1196.66%)

801,593 (-91.49%)

9,414,104 (0.58%)

9,359,782 (49.94%)